Upgrade to SI Premium - Free Trial

FDA accepts Cogent Biosciences NDA for bezuclastinib in AdvSM

September 15, 2026 8:01 AM
Cogent Biosciences, Inc. (Nasdaq: COGT) announced that the U.S. Food and Drug Administration has accepted its New Drug Application for ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

FDA